Modafinil reduces depression's severity when taken with antidepressants

November 27, 2013, University of Cambridge

A new study has concluded that taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone. The study, a collaboration between the Universities of Cambridge and East London and King's College London, was published online in the Journal of Clinical Psychiatry.

Approximately a third of receive little or no benefit from taking even when used in combination with psychological counseling. Furthermore, of those who respond to treatment, such as fatigue and trouble sleeping pose risk factors for relapse. The authors of the study believe that these individuals in particular would benefit the most from supplementing their antidepressants with modafinil.

Professor Barbara Sahakian from the University of Cambridge said, "Modafinil has actions on a number of neurotransmitter systems. This may explain why adding it to traditional anti-depressants, such as selective serotonin reuptake inhibitors, has on the symptoms experienced by depressed patients."

"This is good news for individuals struggling to fight ," said Professor Cynthia Fu from University of East London, who undertook the research whilst at King's College London. "Depression affects all aspects of life, leading to occupational and social disability at varying levels. It is particularly important that people receive effective treatment as the residual symptoms - e.g. fatigue, lack of concentration etc. - can persist and have a negative impact in people's lives."

For the research, the scientists reviewed various studies which had examined the use of modafinil as an add-on treatment for depression. The meta-analysis involved a total of 568 patients with unipolar depression and a total of 342 patients with bipolar depression. The analysis revealed that modafinil improved the severity of depression as well as remission rates. Modafinil also showed beneficial effects on fatigue and sleepiness, with the added benefit of the comparable side effects to placebo.

The research also revealed that the symptomatic benefits of modafinil might also have implications for improving the difficulty of functioning at work sometimes caused by depression. This is significant because depression is a major cause of absenteeism (absence due to sick leave) and presenteeism (present at work but not functioning as before).

Dr Muzaffer Kaser from the University of Cambridge added: "The next step is for longer trials to evaluate potential benefits of supplementing antidepressants with more comprehensively."

Depression is a major global health problem. According to the World Health Organisation, it is estimated to be the second leading cause of disability worldwide by 2020. Recent studies revealed that depression represents more than a third of global burden of disease attributable to mental health problems*. The annual cost of mood disorders to the UK economy is estimated to be around £16 billion**. Disability caused by depression is mainly due to the on work and social functioning and its relapsing nature.

Explore further: Exercise for depression: Some benefits but better trials are needed

More information: 1. The paper 'Modafinil Augmentation Therapy in Unipolar and Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials' is published in the November edition of Journal of Clinical Psychiatry.

2. *Whiteford HA. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet DOI: 10.1016/S0140-6736(13)61611-6

**Fineberg, NA, et al. "The size, burden and cost of disorders of the brain in the UK." Journal of Psychopharmacology 27.9 (2013): 761-770

Related Stories

Exercise for depression: Some benefits but better trials are needed

September 11, 2013
Exercise may benefit people suffering from depression, according to an updated systematic review published in The Cochrane Library. The authors of the review found evidence to suggest that exercise reduces symptoms of depression, ...

Biomarkers to finetune depression treatment

November 8, 2013
The use of inflammatory and oxidative stress biomarkers in psychiatry may have the potential to improve treatment efficacy and aid in the diagnosis of major depression, a review has found.

Varenicline helps smokers with depression to quit smoking

September 16, 2013
About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder (MDD) have greater difficulty quitting.

Biochemical mapping helps explain who will respond to antidepressants

July 18, 2013
Duke Medicine researchers have identified biochemical changes in people taking antidepressants – but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal ...

Depression second leading cause of global disability burden

November 5, 2013
A study published this week in PLOS Medicine reports the most recent and comprehensive estimates on how much death and disability is attributable to depression, both world-wide and in individual countries and regions.

Recommended for you

Study listens in on speech development in early childhood

January 15, 2018
If you've ever listened in on two toddlers at play, you might have wondered how much of their babbling might get lost in translation. A new study from the University of Toronto provides surprising insights into how much children ...

Study suggests people dislike you more for humblebragging than for regular boasting

January 12, 2018
A team of researchers from Harvard University and UNC-Chapel Hill has conducted a study regarding humblebragging—in which a person boasts about an achievement but tries to make it sound less boastful by minimizing it—and ...

Can writing your 'to-do's' help you to doze? Study suggests jotting down tasks can speed the trip to dreamland

January 11, 2018
Writing a "to-do" list at bedtime may aid in falling asleep, according to a Baylor University study. Research compared sleep patterns of participants who took five minutes to write down upcoming duties versus participants ...

Study identifies brain circuit controlling social behavior

January 11, 2018
A new study by researchers at Roche in Basel, Switzerland has identified a key brain region of the neural circuit that controls social behavior. Increasing the activity of this region, called the habenula, led to social problems ...

Tamper-resistant oxycodone tablets have no impact on overall opioid use

January 11, 2018
The introduction of tamper-resistant opioid tablets does not have an effect on rates of opioid use or harms at a population level, according to a new study led by the National Drug and Alcohol Research Centre (NDARC) at UNSW ...

Suicides by drugs in U.S. are undercounted, new study suggests

January 11, 2018
The rate of suicides by drug intoxication in the United States may be vastly underreported and misclassified, according to a new study co-written by Mark Kaplan, professor of social welfare at the UCLA Luskin School of Public ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.